Search research articles
Contact Us
Filters
Showing results (351-360 of 359) with videos related to
Page
of 36
Sort By:
You have reached the last page of results.
This site can display upto 359 results.
Medical Mycology
|
March 25, 2026
A decade of ocular fungal infections due to Penicillium-like fungi in France (2012 to 2021)
Lorra Monpierre, Eric Dannaoui, Olivier Lortholary, et al.
Medicina (Kaunas, Lithuania)
|
March 26, 2022
Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature
Margot Denier, Sarah Tick, Romain Dubois, et al.
The Journal of Experimental Medicine
|
February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages
Ommar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Blood Advances
|
March 15, 2022
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Blood
|
September 22, 2020
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.
American Journal of Hematology
|
June 21, 2021
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)
Grégory Lazarian, Michaël Munger, Anne Quinquenel, et al.
American Journal of Hematology
|
April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study
Matthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.
Eclinicalmedicine
|
January 8, 2026
Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group
Anne Quinquenel, Rémi Letestu, Magali Le Garff-Tavernier, et al.
Page
of 36
Search research articles
Search
Showing results (351-360 of 359) with videos related to
Sort By:
Page
of 36
You have reached the last page of results.
This site can display upto 359 results.
Medical Mycology
|
March 25, 2026
A decade of ocular fungal infections due to Penicillium-like fungi in France (2012 to 2021)
Lorra Monpierre, Eric Dannaoui, Olivier Lortholary, et al.
Medicina (Kaunas, Lithuania)
|
March 26, 2022
Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature
Margot Denier, Sarah Tick, Romain Dubois, et al.
The Journal of Experimental Medicine
|
February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages
Ommar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Blood Advances
|
March 15, 2022
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Blood
|
September 22, 2020
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.
American Journal of Hematology
|
June 21, 2021
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)
Grégory Lazarian, Michaël Munger, Anne Quinquenel, et al.
American Journal of Hematology
|
April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study
Matthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.
Eclinicalmedicine
|
January 8, 2026
Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group
Anne Quinquenel, Rémi Letestu, Magali Le Garff-Tavernier, et al.
Page
of 36